To further understand the intrinsic mechanisms for hypoglycemia/hypoxia susceptibilities of β-cells, we produced novel transgenic (Tg) mice with HIMP1-a overexpression by the control of mouse insulin 1 gene promoter (MIP, ∼8.3 kb in length). The gene discussed is HM13; the disease is Hypoglycemia.